Therapeutic strategies for pediatric non-alcoholic fatty liver disease: A challenge for health care providers [1]

Research output: Contribution to journalArticlepeer-review

Abstract

Non-alcoholic steato-hepatitis (NASH) is related to insulin resistance and, thus, frequently occurs as part of the metabolic changes that accompany obesity, diabetes and hyperlipidemia. In childhood, the overwhelming boost of obesity and its co-morbidities have lead to the extraordinarily increased prevalence of NASH. Establishing effective therapeutic strategies to treat the disease represents the challenge for hepatologists and gastroenterologists in the next decade. Therapeutic approaches have aimed at treating associated conditions (obesity, insulin resistance, hyperlipemia, etc) or reducing liver oxidative damage (vitamin E).

Original languageEnglish
Pages (from-to)2639-2641
Number of pages3
JournalWorld Journal of Gastroenterology
Volume13
Issue number18
Publication statusPublished - May 14 2007

Keywords

  • Insulin resistance
  • Non alcoholic steato-hepatitis
  • Non-alcoholic fatty liver disease
  • Thiazolidinediones
  • Vitamin E, diet

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Therapeutic strategies for pediatric non-alcoholic fatty liver disease: A challenge for health care providers [1]'. Together they form a unique fingerprint.

Cite this